Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
The Journal of Infectious Diseases
|
June 16, 2007
Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols?
Graham A W Rook, Douglas B Lowrie, Rogelio Hernàndez-Pando
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 3, 2024
Natural products in anti-tuberculosis host-directed therapy
Xuejiao Huang, Douglas B Lowrie, Xiao-Yong Fan, et al.
The Lancet. Infectious Diseases
|
December 28, 2018
The predictive values of the tuberculin skin test and interferon-γ release assays for active tuberculosis development
Zhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
Frontiers in Immunology
|
July 11, 2022
Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
Zhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
The Journal of Infectious Diseases
|
March 20, 2019
Reply to Tonby et al
Zhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
Medcomm
|
March 14, 2022
Trained immunity: A Yin-Yang balance
Zhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
Scientific Reports
|
January 14, 2021
Tailored co-localization analysis of intracellular microbes and punctum-distributed phagosome-lysosome pathway proteins using ImageJ plugin EzColocalization
Kang Wu, Bo Yan, Douglas B Lowrie, et al.
European Journal of Immunology
|
February 19, 2004
CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells
Pål Johansen, Panagiota Stamou, Ricardo E Tascon, et al.
Frontiers in Medicine
|
March 3, 2020
Probe Signal Values in mRNA Arrays Imply an Excessive Involvement of Neutrophil FCGR1 in Tuberculosis
Kang Wu, Meng Li, Zhen-Yan Chen, et al.
Infection
|
March 17, 2025
The blood biomarker combination IL-8/IL-33 and IL-18/IL-33 distinguish between active tuberculosis and latent infection
Huimin Zhao, Zhenyan Chen, Douglas B Lowrie, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
The Journal of Infectious Diseases
|
June 16, 2007
Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols?
Graham A W Rook, Douglas B Lowrie, Rogelio Hernàndez-Pando
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 3, 2024
Natural products in anti-tuberculosis host-directed therapy
Xuejiao Huang, Douglas B Lowrie, Xiao-Yong Fan, et al.
The Lancet. Infectious Diseases
|
December 28, 2018
The predictive values of the tuberculin skin test and interferon-γ release assays for active tuberculosis development
Zhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
Frontiers in Immunology
|
July 11, 2022
Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
Zhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
The Journal of Infectious Diseases
|
March 20, 2019
Reply to Tonby et al
Zhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
Medcomm
|
March 14, 2022
Trained immunity: A Yin-Yang balance
Zhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
Scientific Reports
|
January 14, 2021
Tailored co-localization analysis of intracellular microbes and punctum-distributed phagosome-lysosome pathway proteins using ImageJ plugin EzColocalization
Kang Wu, Bo Yan, Douglas B Lowrie, et al.
European Journal of Immunology
|
February 19, 2004
CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells
Pål Johansen, Panagiota Stamou, Ricardo E Tascon, et al.
Frontiers in Medicine
|
March 3, 2020
Probe Signal Values in mRNA Arrays Imply an Excessive Involvement of Neutrophil FCGR1 in Tuberculosis
Kang Wu, Meng Li, Zhen-Yan Chen, et al.
Infection
|
March 17, 2025
The blood biomarker combination IL-8/IL-33 and IL-18/IL-33 distinguish between active tuberculosis and latent infection
Huimin Zhao, Zhenyan Chen, Douglas B Lowrie, et al.
Page
of 6